Lipid-Modified Aminoglycoside Derivatives for In Vivo siRNA Delivery

ADVANCED MATERIALS

卷 25, 期 33, 页码 4641-4645

WILEY-V C H VERLAG GMBH

siRNA; drug delivery; nanoparticle; gene knockdown; aminoglycoside

Chemistry, Multidisciplinary Chemistry, Physical Nanoscience & Nanotechnology Materials Science, Multidisciplinary Physics, Applied Physics, Condensed Matter

1. Alnylam Pharmaceuticals, Inc.
2. NIH [EB000244, 1-RO1-CA132091-03]
3. Damon Runyon Cancer Research Foundation (DFS) [2050-10]